确定TNFAIP2作为CSF-1受体激活的独特细胞调节剂
Randa A Abdelnaser1, Masateru Hiyoshi2, Naofumi Takahashi1
1Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan.
Life science alliance
|February 12, 2025
概括
细胞蛋白TNFAIP2通过PIP2结合促进其聚合,从而调节CSF-1受体 (CSF1R) 的激活. 这种机制增强了CSF1R二分化和巨细胞的反应,提供了治疗见解.
科学领域:
- 细胞生物学 细胞生物学
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 殖民地刺激因子1受体 (CSF1R) 对于巨细胞发育至关重要,也是瘤学中的治疗点.
- 在巨细胞中调节CSF1R激活和聚合物形成的机制仍然不完全理解.
研究的目的:
- 为了确定CSF1R激活和聚合物形成的新型调节者.
- 阐明TNFAIP2影响CSF1R功能的分子机制.
主要方法:
- 研究了TNF-α诱导蛋白2 (TNFAIP2) 在CSF1R调节中的作用,使用巨细胞和293个细胞的淘汰和过度表达研究.
- 通过使用生化和细胞成像技术,评估了酸丁酸4,5-双酸盐 (PIP2) 的CSF1R聚合物形成,激活和细胞分布.
- 在CSF1R和TNFAIP2中使用PIP2结合基因的突变性来确定它们的功能意义.
主要成果:
- TNFAIP2被确定为一种新型调节剂,促进CSF1R聚合物的形成,并增强CSF-1诱导的CSF1R激活.
- 抑制或淘汰TNFAIP2降低了CSF1R聚合和巨对CSF-1的反应能力.
- CSF1R和TNFAIP2都与PIP2结合;TNFAIP2改变PIP2的细胞分布,而PIP2结合或耗尽的破坏会减少CSF1R的聚合.
结论:
- 通过与PIP2相互作用,TNFAIP2促进CSF1R聚合物的形成,从而促进CSF1R单体的接近性和在CSF-1刺激时有效的二元化/激活.
- 这些发现揭示了涉及TNFAIP2和PIP2的CSF1R激活的新型调节途径,这对巨细胞生物学和癌症治疗有意义.
相关概念视频
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
NF-κB-dependent Signaling Pathway
7.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.2K
Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K


